Angioimmunoblastic T-cell lymphoma epidemiology and demographics
|
Angioimmunoblastic T-cell lymphoma Microchapters |
|
Differentiating Angioimmunoblastic T-cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Angioimmunoblastic T-cell lymphoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Angioimmunoblastic T-cell lymphoma epidemiology and demographics |
|
FDA on Angioimmunoblastic T-cell lymphoma epidemiology and demographics |
|
CDC on Angioimmunoblastic T-cell lymphoma epidemiology and demographics |
|
Angioimmunoblastic T-cell lymphoma epidemiology and demographics in the news |
|
Blogs on Angioimmunoblastic T-cell lymphoma epidemiology and demographics |
|
Directions to Hospitals Treating Angioimmunoblastic T-cell lymphoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [3] Sowminya Arikapudi, M.B,B.S. [4]
Overview
Angioimmunoblastic T-cell lymphoma commonly affects middle-aged or elderly. Angioimmunoblastic T-cell lymphoma affects men and women equally. [1]
Age
Angioimmunoblastic T-cell lymphoma commonly affects middle-aged or elderly.
Gender
Angioimmunoblastic T-cell lymphoma affects men and women equally.